BioGaia AB (publ) (STO:BIOG.B)
Sweden · Delayed Price · Currency is SEK 121.90
+2.90 (2.44%)
Nov 4, 2026, 5:29 PM CET
BioGaia AB Financials Overview
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,654 | 1,538 | 1,423 | 1,297 | 1,104 | 785.11 |
Revenue Growth | 13.13% | 8.12% | 9.74% | 17.44% | 40.61% | 5.09% |
Gross Profit Gross Profit Growth | 1,203 | 1,129 | 1,031 | 950.19 | 801.93 | 582.95 |
Operating Income Operating Income Growth | 466.95 | 451.97 | 460.51 | 440.91 | 334.51 | 246.72 |
Net Income Net Income Growth | 391.56 | 332.76 | 351.39 | 365.35 | 373.77 | 196.27 |
Earnings Per Share EPS Growth | 3.87 | 3.29 | 3.48 | 3.62 | 3.70 | 1.94 |
EPS Growth | 24.16% | -5.38% | -3.91% | -2.22% | 90.72% | -3.64% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pediatrics Pediatrics Growth | 1,178 | 1,154 | 1,093 | 1,014 | 868.36 | 603.69 |
Adult Health Adult Health Growth | 393.15 | 372.53 | 321.29 | 275.23 | 230.21 | 176.86 |
Other Segment Other Segment Growth | 9.55 | 11.62 | 8.15 | 7.75 | 5.4 | 4.57 |
Revenue (Total) Revenue (Total) Growth | 1,581 | 1,538 | 1,423 | 1,297 | 1,104 | 785.11 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 518.28 | 801.31 | 1,224 | 1,544 | 1,488 | 1,485 |
Total Debt Total Debt Growth | - | 23.16 | 29.48 | 35.16 | 16.01 | 9.81 |
Net Cash (Debt) Net Cash Growth | 518.28 | 778.15 | 1,195 | 1,509 | 1,472 | 1,475 |
Net Cash Growth | -28.82% | -34.86% | -20.84% | 2.49% | -0.17% | 2.05% |
Net Cash Per Share Net Cash Per Share Growth | 5.12 | 7.69 | 11.82 | 14.94 | 14.58 | 14.61 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 284.45 | 306.57 | 373.22 | 425.97 | 318.94 | 221.88 |
Capital Expenditures CapEx Growth | -26.07 | -3.52 | -13.76 | -48.57 | -17.92 | -6.38 |
Free Cash Flow Free Cash Flow Growth | 258.38 | 303.04 | 359.46 | 377.4 | 301.03 | 215.5 |
Free Cash Flow Growth | -19.86% | -15.70% | -4.75% | 25.37% | 39.69% | 5.03% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 72.74% | 73.37% | 72.45% | 73.29% | 72.64% | 74.25% |
Operating Margin | 28.23% | 29.38% | 32.37% | 34.01% | 30.30% | 31.42% |
Pretax Margin | 29.82% | 27.38% | 31.48% | 36.16% | 40.55% | 32.19% |
Profit Margin | 23.67% | 21.63% | 24.70% | 28.18% | 33.86% | 25.00% |
FCF Margin | 15.62% | 19.70% | 25.27% | 29.11% | 27.27% | 27.45% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 4.000 | 1.640 | 1.950 | 1.900 | 1.450 | 0.730 |
Dividend Per Share Growth | -42.03% | -15.90% | 2.63% | 31.03% | 98.63% | 7.04% |
Dividend Yield | 3.28% | 1.54% | 1.74% | 1.88% | 1.74% | 0.70% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 31.50 | 32.28 | 32.22 | 27.97 | 22.58 | 53.30 |
Forward PE | 25.62 | 27.23 | 29.29 | 26.42 | 29.95 | 50.89 |
P/FCF Ratio | 47.10 | 35.45 | 31.49 | 27.08 | 28.03 | 48.55 |
PS Ratio | 7.36 | 6.99 | 7.96 | 7.88 | 7.64 | 13.33 |